Corvus Pharmaceuticals, Inc. (CRVS) › Total LiabilitiesCorvus Pharmaceuticals, Inc. (CRVS) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $3.78M2016: $7.35M2017: $9.94M2018: $7.90M2019: $12.54M2020: $13.38M2021: $12.29M2022: $12.12M2023: $6.87M2024: $36.34M2025: $9.91M$9.91M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$9.91M-72.7%2024$36.34M+429.0%2023$6.87M-43.3%2022$12.12M-1.4%2021$12.29M-8.1%2020$13.38M+6.7%2019$12.54M+58.8%2018$7.90M-20.6%2017$9.94M+35.3%2016$7.35M+94.4%2015$3.78M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share